(30)In determining whether an OTC derivative contract reduces risks directly relating to the commercial activities and treasury activities of a non-financial counterparty, due account should be taken of that non-financial counterparty’s overall hedging and risk-mitigation strategies. In particular, consideration should be given to whether an OTC derivative contract is economically appropriate for the reduction of risks in the conduct and management of a non-financial counterparty, where the risks relate to fluctuations in interest rates, foreign exchange rates, inflation rates or commodity prices.
◷
New version applies from 01/01/2014 — introduced by Capital Requirements Regulation (CRR), Commission Delegated Regulation (EU) No 1002/2013.
191 provisions change.
Later versions: 02/07/2014, 25/06/2015, 16/09/2015, 12/01/2016, 03/01/2017, 01/04/2017, 30/06/2017, 01/01/2019, 17/06/2019, 18/12/2019, 01/01/2020, 18/06/2020, 11/02/2021, 13/02/2021, 28/06/2021, 12/08/2022, 24/12/2024, 17/01/2025.
Recital 30 changes in this version: compare with the current text.